Back to Search
RICHARD DEVEREUX, MD
MD
Cardiovascular Disease Physician
NPI: 1134216237IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
113971(NY)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 1971
Research & Publications (20)
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
PMID 17288698·Curr Med Res Opin·2007
4-observational
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
PMID 17288679·Curr Med Res Opin·2007
4-observational
Prognostic significance of left ventricular mass change during treatment of hypertension.
PMID 15547162·JAMA·2004
3-trial
Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
PMID 15500378·Expert Opin Pharmacother·2004
6-review
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
PMID 15326072·Circulation·2004
3-trial
Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study.
PMID 12947374·Am Heart J·2003
8-other
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
PMID 12899584·Ann Intern Med·2003
3-trial
An appraisal of echocardiography as an epidemiological tool. The Strong Heart Study.
PMID 12684189·Ann Epidemiol·2003
8-other
Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study.
PMID 12460697·Am J Hypertens·2002
4-observational
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
PMID 12131543·J Hypertens·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 520 E 70TH ST # STARR-4
NEW YORK, NY 10021 - Phone
- (212) 746-4655
Quick Facts
- NPI
- 1134216237
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 55
- Publications
- 20
Are you this provider?
Claim Your Profile